Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection, Date of authorisation: 15/01/2009, Revision: 4

Human medicines European public assessment report (EPAR): RoActemra, tocilizumab, Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection, Date of authorisation: 15/01/2009, Revision: 41, Status: Authorised